Form 4 for CATX Perspective Therapeutics, Inc.
Accepted 2024-03-08 00:00:00 ET · period of report 2024-03-06 · accession 0000950170-24-028446 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-03-08 | 2024-03-06 | CATX | Lantheus Alpha Therapy, LLC | 10% | P - Purchase | $0.95 | +60.43M | 116.77M | +107% | +$57.41M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-06 | P | A | 60,431,039 | $0.95 | 116,773,394 | D | — | — | (F1) Represents securities directly held by Lantheus Alpha Therapy, LLC, ("Lantheus"), a wholly owned direct subsidiary of Lantheus Holdings, Inc. ("Lantheus Holdings"). Under SEC rules and regulations, Lantheus Holdings may be deemed to have indirect beneficial ownership of the shares held by Lantheus, which has direct beneficial ownership. |